[Cardioprotection through ACE inhibition. Satellite symposium of the 12th scientific meeting of the International Society of Hypertension. 26 May 1988, Kyoto, Japan].
出版信息
Fortschr Med Suppl. 1988;51:1-17.
PMID:2904397
Abstract
摘要
相似文献
1
2
3
4
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.心血管疾病中血管紧张素转换酶抑制剂专家共识文件。欧洲心脏病学会血管紧张素转换酶抑制剂工作组。
Eur Heart J. 2004 Aug;25(16):1454-70. doi: 10.1016/j.ehj.2004.06.003.
5
6
[The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors].
Schweiz Rundsch Med Prax. 1988 Jun 14;77(24):673-9.
7
[ACE inhibition in tissues. Decisive for prognosis?].[组织中的血管紧张素转换酶抑制作用。对预后起决定性作用？]
MMW Fortschr Med. 2002 Mar 14;144(11):60.
8
The chymase-angiotensin system in humans: biochemistry, molecular biology and potential role in cardiovascular diseases.人类的糜酶 - 血管紧张素系统：生物化学、分子生物学及其在心血管疾病中的潜在作用。
Can J Cardiol. 1995 Aug;11 Suppl F:13F-19F.
9
ACE inhibitors in cardiovascular disease. Which patient? Which drug? Which dose?心血管疾病中的血管紧张素转换酶抑制剂。哪些患者适用？用哪种药物？用多大剂量？
Aust Fam Physician. 1996 Jul;25(7):1067-9, 1072-3, 1076-7.
10
[Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].[血管紧张素转换酶抑制与心血管疾病预防：二十多年的临床成功经验]
Ital Heart J Suppl. 2005 Dec;6(12):769-79.
Zotero 插件